Artwork

Content provided by Cannabis Radio. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Cannabis Radio or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

Oil Applicators or Synthetic Cannabinoids

48:25
 
Share
 

Manage episode 380170446 series 3035057
Content provided by Cannabis Radio. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Cannabis Radio or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

Mike McDonald is President at Dablicator and how their patented oil applicator continues to connect with more brands. Experienced in consumer products manufacturing, finance, marketing, and sales, Mike has guided Ammonite’s rapid development from a start-up to one of the most innovative hardware platforms in the cannabis industry.

Originally created by one of California’s leading cannabis brands, Dablicator partners with vertically integrated operators and premium extract brands to deliver the easiest, most versatile way to experience cannabis. Their patented Dablicator™ oil applicator is designed to replace a messy syringe and is ideal for all oil types including live rosin, solventless, live resin, RSO, distillate, hemp CBD, and more. The Dablicator brand partner program provides a turnkey solution with fully brandable hardware, packaging, and marketing materials that drive product innovation and accretive retail revenue with your brand and your oil.

Dr. Jim Woody, CEO and Director of 180 Life Sciences, a clinical-stage biotechnology company. 180 Life Sciences aims to develop SCAs that are safe, non-psychoactive, and formulated to improve efficacy and bioavailability – a real alternative to unregulated cannabidiol (CBD). Through this program, 180 Life Sciences is working on orally available SCAs, not derived from plants, to address the deleterious issues of medical cannabis. If successful, these SCAs could offer a robustly consistent and safe dosage that allows patient intake to be carefully controlled.


Advertising Inquiries: https://redcircle.com/brands
Privacy & Opt-Out: https://redcircle.com/privacy
  continue reading

390 episodes

Artwork

Oil Applicators or Synthetic Cannabinoids

Blunt Business

0-10 subscribers

published

iconShare
 
Manage episode 380170446 series 3035057
Content provided by Cannabis Radio. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Cannabis Radio or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

Mike McDonald is President at Dablicator and how their patented oil applicator continues to connect with more brands. Experienced in consumer products manufacturing, finance, marketing, and sales, Mike has guided Ammonite’s rapid development from a start-up to one of the most innovative hardware platforms in the cannabis industry.

Originally created by one of California’s leading cannabis brands, Dablicator partners with vertically integrated operators and premium extract brands to deliver the easiest, most versatile way to experience cannabis. Their patented Dablicator™ oil applicator is designed to replace a messy syringe and is ideal for all oil types including live rosin, solventless, live resin, RSO, distillate, hemp CBD, and more. The Dablicator brand partner program provides a turnkey solution with fully brandable hardware, packaging, and marketing materials that drive product innovation and accretive retail revenue with your brand and your oil.

Dr. Jim Woody, CEO and Director of 180 Life Sciences, a clinical-stage biotechnology company. 180 Life Sciences aims to develop SCAs that are safe, non-psychoactive, and formulated to improve efficacy and bioavailability – a real alternative to unregulated cannabidiol (CBD). Through this program, 180 Life Sciences is working on orally available SCAs, not derived from plants, to address the deleterious issues of medical cannabis. If successful, these SCAs could offer a robustly consistent and safe dosage that allows patient intake to be carefully controlled.


Advertising Inquiries: https://redcircle.com/brands
Privacy & Opt-Out: https://redcircle.com/privacy
  continue reading

390 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Quick Reference Guide